The Complexities in Genotyping of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency

Moran, 2000, 21-Hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study, Am J Obstet Gynecol., 183, 1468, 10.1067/mob.2000.108020

White, 2000, Congenital adrenal hyperplasia due to 21-hydroxylase deficiency, Endocr Rev., 21, 245, 10.1210/edrv.21.3.0398

Speiser, 2003, Congenital adrenal hyperplasia, N Engl J Med., 349, 776, 10.1056/NEJMra021561

Kuttenn, 1985, Late-onset adrenal hyperplasia in hirsutism, N Engl J Med., 313, 224, 10.1056/NEJM198507253130404

Pang, 1988, Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency, Pediatrics., 81, 866

Pang, 1990, Newborn screening, prenatal diagnosis, and prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency, Trends Endocrinol Metab., 1, 300, 10.1016/1043-2760(90)90068-E

Pang, 1997, Current status of neonatal screening for congenital adrenal hyperplasia, Curr Opin Pediatr., 9, 419, 10.1097/00008480-199708000-00018

van der Kamp, 2004, Neonatal screening for congenital adrenal hyperplasia, Eur J Endocrinol., 151, U71, 10.1530/eje.0.151u071

White, 2009, Neonatal screening for congenital adrenal hyperplasia, Nat Rev Endocrinol., 5, 490, 10.1038/nrendo.2009.148

Therrell, 1998, Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia, Pediatrics., 101, 583, 10.1542/peds.101.4.583

Pearce, 2016, Newborn screening for congenital adrenal hyperplasia in New York State, Mol Genet Metab Rep., 7, 1, 10.1016/j.ymgmr.2016.02.005

Carmina, 1990, Pituitary-adrenal responses to corticotropin-releasing factor in late onset 21-hydroxylase deficiency, Fertil Steril., 54, 79, 10.1016/S0015-0282(16)53640-1

Azziz, 1994, Clinical review 56: nonclassic adrenal hyperplasia: current concepts, J Clin Endocrinol Metab., 78, 810, 10.1210/jcem.78.4.8157702

Huerta, 2000, Adrenocortical hyperresponsivity to adrenocorticotropic hormone: a mechanism favoring the normal production of cortisol in 21-hydroxylase-deficient nonclassic adrenal hyperplasia, Fertil Steril., 74, 329, 10.1016/S0015-0282(00)00631-2

Witchel, 2010, Nonclassic congenital adrenal hyperplasia, Int J Pediatr Endocrinol., 2010, 625105, 10.1155/2010/625105

Pall, 2010, The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia, Fertil Steril., 94, 684, 10.1016/j.fertnstert.2009.06.025

Azziz, 2004, Androgen excess in women: experience with over 1000 consecutive patients, J Clin Endocrinol Metab., 89, 453, 10.1210/jc.2003-031122

New, 2006, Extensive clinical experience: nonclassical 21-hydroxylase deficiency, J Clin Endocrinol Metab., 91, 4205, 10.1210/jc.2006-1645

Escobar-Morreale, 2008, A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs, J Clin Endocrinol Metab., 93, 527, 10.1210/jc.2007-2053

Fanta, 2008, Prevalence of nonclassic adrenal hyperplasia (NCAH) in hyperandrogenic women, Gynecol Endocrinol., 24, 154, 10.1080/09513590801911992

Carmina, 2017, Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women, Hum Reprod Update., 23, 580, 10.1093/humupd/dmx014

Speiser, 1985, High frequency of nonclassical steroid 21-hydroxylase deficiency, Am J Hum Genet., 37, 650

Parajes, 2007, A simple and robust quantitative PCR assay to determine CYP21A2 gene dose in the diagnosis of 21-hydroxylase deficiency, Clin Chem., 53, 1577, 10.1373/clinchem.2007.087361

Parajes, 2008, High frequency of copy number variations and sequence variants at CYP21A2 locus: implication for the genetic diagnosis of 21-hydroxylase deficiency, PLoS ONE., 3, e2138, 10.1371/journal.pone.0002138

Higashi, 1986, Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene, Proc Natl Acad Sci USA., 83, 2841, 10.1073/pnas.83.9.2841

White, 1986, Structure of human steroid 21-hydroxylase genes, Proc Natl Acad Sci USA., 83, 5111, 10.1073/pnas.83.14.5111

Sweeten, 2008, C4B null alleles are not associated with genetic polymorphisms in the adjacent gene CYP21A2 in autism, BMC Med Genet., 9, 1, 10.1186/1471-2350-9-1

Yang, 1999, Modular variations of the human major histocompatibility complex class III genes for serine/threonine kinase RP, complement component C4, steroid 21-hydroxylase CYP21, and tenascin TNX (the RCCX module), J Biol Chem., 274, 12147, 10.1074/jbc.274.17.12147

Carroll, 1985, Mapping of steroid 21-hydroxylase genes adjacent to complement component C4 genes in HLA, the major histocompatibility complex in man, Proc Natl Acad Sci USA., 82, 521, 10.1073/pnas.82.2.521

White, 1985, Adrenal 21-hydroxylase cytochrome P-450 genes within the MHC class III region, Immunol Rev., 87, 123, 10.1111/j.1600-065X.1985.tb01148.x

Blanchong, 2000, Deficiencies of human complement component C4A and C4B and heterozygosity in length variants of RP-C4-CYP21-TNX (RCCX) modules in caucasians, J Exp Med., 191, 2183, 10.1084/jem.191.12.2183

Haglund-Stengler, 1991, Haplotypes of the steroid 21-hydroxylase gene region encoding mild steroid 21-hydroxylase deficiency, Proc Natl Acad Sci USA., 88, 8352, 10.1073/pnas.88.19.8352

Sinnott, 1991, Extended MHC haplotypes and CYP21/C4 gene organisation in Irish 21-hydroxylase deficiency families, Hum Genet., 87, 361, 10.1007/BF00200920

Koppens, 2002, Duplication of the CYP21A2 gene complicates mutation analysis of steroid 21-hydroxylase deficiency: characteristics of three unusual haplotypes, Hum Genet., 111, 405, 10.1007/s00439-002-0810-7

Miller, 1994, Clinical review 54: genetics, diagnosis, and management of 21-hydroxylase deficiency, J Clin Endocrinol Metab., 78, 241, 10.1210/jcem.78.2.8106606

Speiser, 2001, Molecular diagnosis of CYP21 mutations in congenital adrenal hyperplasia: implications for genetic counseling, Am J Pharmacogenomics., 1, 101, 10.2165/00129785-200101020-00003.

Parker, 2006, Maternal 21-hydroxylase deficiency and uniparental isodisomy of chromosome 6 and X results in a child with 21-hydroxylase deficiency and Klinefelter syndrome, Am J Med Genet A., 140, 2236, 10.1002/ajmg.a.31408

Simonetti, 2018, CYP21A2 mutation update: comprehensive analysis of databases and published genetic variants, Hum Mutat., 39, 5, 10.1002/humu.23351

Araujo, 2007, Microconversion between CYP21A2 and CYP21A1P promoter regions causes the nonclassical form of 21-hydroxylase deficiency, J Clin Endocrinol Metab., 92, 4028, 10.1210/jc.2006-2163

Higashi, 1988, Evidence for frequent gene conversion in the steroid 21-hydroxylase P-450(C21) gene: implications for steroid 21-hydroxylase deficiency, Am J Hum Genet., 42, 17

Tusie-Luna, 1995, Gene conversions and unequal crossovers between CYP21 (steroid 21-hydroxylase gene) and CYP21P involve different mechanisms, Proc Natl Acad Sci USA., 92, 10796, 10.1073/pnas.92.23.10796

Wedell, 1998, Molecular genetics of congenital adrenal hyperplasia (21-hydroxylase deficiency): implications for diagnosis, prognosis and treatment, Acta Paediatr., 87, 159, 10.1111/j.1651-2227.1998.tb00968.x

White, 1984, HLA-linked congenital adrenal hyperplasia results from a defective gene encoding a cytochrome P-450 specific for steroid 21-hydroxylation, Proc Natl Acad Sci USA., 81, 7505, 10.1073/pnas.81.23.7505

L'Allemand, 2000, How a patient homozygous for a 30-kb deletion of the C4-CYP 21 genomic region can have a nonclassic form of 21-hydroxylase deficiency, J Clin Endocrinol Metab., 85, 4562, 10.1210/jcem.85.12.7018

Lee, 2003, Deletion of the C4-CYP21 repeat module leading to the formation of a chimeric CYP21P/CYP21 gene in a 9.3-kb fragment as a cause of steroid 21-hydroxylase deficiency, Clin Chem., 49, 319, 10.1373/49.2.319

Lee, 2004, The chimeric CYP21P/CYP21 gene and 21-hydroxylase deficiency, J Hum Genet., 49, 65, 10.1007/s10038-003-0115-2

Concolino, 2009, A new CYP21A1P/CYP21A2 chimeric gene identified in an Italian woman suffering from classical congenital adrenal hyperplasia form, BMC Med Genet., 10, 72, 10.1186/1471-2350-10-72

Tusie-Luna, 1991, A mutation (Pro-30 to Leu) in CYP21 represents a potential nonclassic steroid 21-hydroxylase deficiency allele, Mol Endocrinol., 5, 685, 10.1210/mend-5-5-685

Wedell, 1994, Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation, J Clin Endocrinol Metab., 78, 1145, 10.1210/jcem.78.5.8175971

Tajima, 1998, Prenatal diagnosis of steroid 21-hydroxylase deficiency by the modified polymerase chain reaction to detect splice site mutation in the CYP21 gene, Endocr J., 45, 291, 10.1507/endocrj.45.291

Higashi, 1988, Aberrant splicing and missense mutations cause steroid 21-hydroxylase [P-450(C21)] deficiency in humans: possible gene conversion products, Proc Natl Acad Sci USA., 85, 7486, 10.1073/pnas.85.20.7486

Higashi, 1991, Effects of individual mutations in the P-450(C21) pseudogene on the P-450(C21) activity and their distribution in the patient genomes of congenital steroid 21-hydroxylase deficiency, J Biochem., 109, 638, 10.1093/oxfordjournals.jbchem.a123433

Chiou, 1990, A missense mutation at Ile172—Asn or Arg356—Trp causes steroid 21-hydroxylase deficiency, J Biol Chem., 265, 3549, 10.1016/S0021-9258(19)39804-7

Tusie-Luna, 1990, Determination of functional effects of mutations in the steroid 21-hydroxylase gene (CYP21) using recombinant vaccinia virus, J Biol Chem., 265, 20916, 10.1016/S0021-9258(17)45304-X

Wilson, 1995, Steroid 21-hydroxylase deficiency: genotype may not predict phenotype, J Clin Endocrinol Metab., 80, 2322, 10.1210/jcem.80.8.7629224

Wu, 1991, Mutations of P450c21 (steroid 21-hydroxylase) at Cys428, Val281, and Ser268 result in complete, partial, or no loss of enzymatic activity, respectively, J Clin Invest., 88, 519, 10.1172/JCI115334

Speiser, 1988, Molecular genetic analysis of nonclassic steroid 21-hydroxylase deficiency associated with HLA-B14, DR1, N Engl J Med., 319, 19, 10.1056/NEJM198807073190104

Barbat, 1995, Screening of CYP21 gene mutations in 129 French patients affected by steroid 21-hydroxylase deficiency, Hum Mutat., 5, 126, 10.1002/humu.1380050205

Blanche, 1997, Exhaustive screening of the 21-hydroxylase gene in a population of hyperandrogenic women, Hum Genet., 101, 56, 10.1007/s004390050586

Stikkelbroeck, 2003, CYP21 gene mutation analysis in 198 patients with 21-hydroxylase deficiency in The Netherlands: six novel mutations and a specific cluster of four mutations, J Clin Endocrinol Metab., 88, 3852, 10.1210/jc.2002-021681

Globerman, 1988, Nonsense mutation causing steroid 21-hydroxylase deficiency, J Clin Invest., 82, 139, 10.1172/JCI113562

Lajic, 1997, A cluster of missense mutations at Arg356 of human steroid 21-hydroxylase may impair redox partner interaction, Hum Genet., 99, 704, 10.1007/s004390050436

Owerbach, 1992, Pro-453 to Ser mutation in CYP21 is associated with nonclassic steroid 21-hydroxylase deficiency, Mol Endocrinol., 6, 1211, 10.1210/mend.6.8.1406699

Barbaro, 2015, In vitro functional studies of rare CYP21A2 mutations and establishment of an activity gradient for nonclassic mutations improve phenotype predictions in congenital adrenal hyperplasia, Clin Endocrinol (Oxf)., 82, 37, 10.1111/cen.12526

Nikoshkov, 1997, Synergistic effect of partially inactivating mutations in steroid 21-hydroxylase deficiency, J Clin Endocrinol Metab., 82, 194, 10.1210/jcem.82.1.3678

de Carvalho, 2016, Molecular CYP21A2 diagnosis in 480 Brazilian patients with congenital adrenal hyperplasia before newborn screening introduction, Eur J Endocrinol., 175, 107, 10.1530/EJE-16-0171

Neocleous, 2018, Genotype is associated to the degree of virilization in patients with classic congenital adrenal hyperplasia, Front Endocrinol (Lausanne)., 9, 733, 10.3389/fendo.2018.00733

Tardy, 2010, Phenotype-genotype correlations of 13 rare CYP21A2 mutations detected in 46 patients affected with 21-hydroxylase deficiency and in one carrier, J Clin Endocrinol Metab., 95, 1288, 10.1210/jc.2009-1202

Helmberg, 1992, R339H and P453S: CYP21 mutations associated with nonclassic steroid 21-hydroxylase deficiency that are not apparent gene conversions, Mol Endocrinol., 6, 1318, 10.1210/mend.6.8.1406709

Bidet, 2009, Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members, J Clin Endocrinol Metab., 94, 1570, 10.1210/jc.2008-1582

Moran, 2006, Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia, J Clin Endocrinol Metab., 91, 3451, 10.1210/jc.2006-0062

Dolzan, 2005, Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in Middle European patients with congenital adrenal hyperplasia, Eur J Endocrinol., 153, 99, 10.1530/eje.1.01944

Menassa, 2008, p.H62L, a rare mutation of the CYP21 gene identified in two forms of 21-hydroxylase deficiency, J Clin Endocrinol Metab., 93, 1901, 10.1210/jc.2007-2701

Speiser, 2000, A multicenter study of women with nonclassical congenital adrenal hyperplasia: relationship between genotype and phenotype, Mol Genet Metab., 71, 527, 10.1006/mgme.2000.3036

Speiser, 1992, Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency, J Clin Invest., 90, 584, 10.1172/JCI115897

Wedell, 1992, Steroid 21-hydroxylase deficiency: three additional mutated alleles and establishment of phenotype-genotype relationships of common mutations, Proc Natl Acad Sci USA., 89, 7232, 10.1073/pnas.89.15.7232

Krone, 2000, Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany, J Clin Endocrinol Metab., 85, 1059, 10.1210/jcem.85.3.6441

Wilson, 2007, Ethnic-specific distribution of mutations in 716 patients with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency, Mol Genet Metab., 90, 414, 10.1016/j.ymgme.2006.12.005

Billerbeck, 1999, A novel missense mutation, GLY424SER, in Brazilian patients with 21-hydroxylase deficiency, J Clin Endocrinol Metab., 84, 2870, 10.1210/jcem.84.8.5937

Billerbeck, 2002, Three novel mutations in CYP21 gene in Brazilian patients with the classical form of 21-hydroxylase deficiency due to a founder effect, J Clin Endocrinol Metab., 87, 4314, 10.1210/jc.2001-011939

Levo, 1997, Mutation-haplotype analysis of steroid 21-hydroxylase (CYP21) deficiency in Finland. Implications for the population history of defective alleles, Hum Genet., 99, 488, 10.1007/s004390050394

Levo, 1999, Tracing past population migrations: genealogy of steroid 21-hydroxylase (CYP21) gene mutations in Finland, Eur J Hum Genet., 7, 188, 10.1038/sj.ejhg.5200262

Kharrat, 2004, Molecular genetic analysis of Tunisian patients with a classic form of 21-hydroxylase deficiency: identification of four novel mutations and high prevalence of Q318X mutation, J Clin Endocrinol Metab., 89, 368, 10.1210/jc.2003-031056

Vakili, 2005, Molecular analysis of the CYP21 gene and prenatal diagnosis in families with 21-hydroxylase deficiency in northeastern Iran, Horm Res., 63, 119, 10.1159/000084570

Delague, 2000, Mutational analysis in Lebanese patients with congenital adrenal hyperplasia due to a deficit in 21-hydroxylase, Horm Res., 53, 77, 10.1159/000023518

Lee, 2004, Use of PCR-based amplification analysis as a substitute for the southern blot method for CYP21 deletion detection in congenital adrenal hyperplasia, Clin Chem., 50, 1074, 10.1373/clinchem.2003.028597

Krone, 2009, Genetics of congenital adrenal hyperplasia, Best Pract Res Clin Endocrinol Metab., 23, 181, 10.1016/j.beem.2008.10.014

Marques, 2010, Mutational characterization of steroid 21-hydroxylase gene in Portuguese patients with congenital adrenal hyperplasia, Exp Clin Endocrinol Diabetes., 118, 505, 10.1055/s-0029-1237363

Ezquieta, 1995, Analysis of steroid 21-hydroxylase gene mutations in the Spanish population, Hum Genet., 96, 198, 10.1007/BF00207379

Oriola, 1997, Rapid screening method for detecting mutations in the 21-hydroxylase gene, Clin Chem., 43, 557, 10.1093/clinchem/43.4.557

Gasser, 2006, Single-strand conformation polymorphism (SSCP) for the analysis of genetic variation, Nat Protoc., 1, 3121, 10.1038/nprot.2006.485

Tajima, 1993, Molecular analysis of patient and carrier genes with congenital steroid 21-hydroxylase deficiency by using polymerase chain reaction and single strand conformation polymorphism, J Clin Invest., 92, 2182, 10.1172/JCI116820

Wilson, 1995, Rapid deoxyribonucleic acid analysis by allele-specific polymerase chain reaction for detection of mutations in the steroid 21-hydroxylase gene, J Clin Endocrinol Metab., 80, 1635, 10.1210/jcem.80.5.7745011

Day, 1995, Detection of steroid 21-hydroxylase alleles using gene-specific PCR and a multiplexed ligation detection reaction, Genomics., 29, 152, 10.1006/geno.1995.1226

O'Donovan, 1998, Blind analysis of denaturing high-performance liquid chromatography as a tool for mutation detection, Genomics., 52, 44, 10.1006/geno.1998.5411

Tsai, 2009, Application of the DHPLC method for mutational detection of the CYP21A2 gene in congenital adrenal hyperplasia, Clin Chim Acta., 410, 48, 10.1016/j.cca.2009.09.020

Krone, 2002, Multiplex minisequencing of the 21-hydroxylase gene as a rapid strategy to confirm congenital adrenal hyperplasia, Clin Chem., 48, 818, 10.1093/clinchem/48.6.818

Morel, 1989, Rearrangements and point mutations of P450c21 genes are distinguished by five restriction endonuclease haplotypes identified by a new probing strategy in 57 families with congenital adrenal hyperplasia, J Clin Invest., 83, 527, 10.1172/JCI113914

Schouten, 2002, Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification, Nucleic Acids Res., 30, e57, 10.1093/nar/gnf056

Krone, 2006, Three novel point mutations of the CYP21 gene detected in classical forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency, Exp Clin Endocrinol Diabetes., 114, 111, 10.1055/s-2005-872841

Loidi, 2006, High variability in CYP21A2 mutated alleles in Spanish 21-hydroxylase deficiency patients, six novel mutations and a founder effect, Clin Endocrinol (Oxf)., 64, 330, 10.1111/j.1365-2265.2006.02465.x

Carvalho, 2012, Comprehensive genetic analysis and structural characterization of CYP21A2 mutations in CAH patients, Exp Clin Endocrinol Diabetes., 120, 535, 10.1055/s-0032-1323805

Witchel, 2017, Congenital Adrenal Hyperplasia, J Pediatr Adolesc Gynecol., 30, 520, 10.1016/j.jpag.2017.04.001